Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study.

Science
Share

First published in Cardiovascular Diabetology on 2013 Apr.
Cardiovasc Diabetol. 2013 Apr 8;12:59. doi: 10.1186/1475-2840-12-59.

Authors: Berndt-Zipfel C, Michelson G, Dworak M, Mitry M, Löffler A, Pfützner A, Forst T

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim

LET’S TALK SCIENCE
Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management

LET’S TALK BUSINESS

You May Also Like

Science 30. Januar 2023
Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects.
Science 30. Januar 2023
Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.
Science 30. Januar 2023
The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial.